Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)

WEB NEWS

Tuesday, October 16, 2012

Comments & Business Outlook

Third Quarter 2012

Revenue   $96,413 an increase from 3rd qtr '11' of $12,218

Net Income  $47,635 an increase from 3rd qtr '11' of $ (20,633)

Diluted  Shares  $0.42 an increase from 3rd qtr '11'(0.21)

  • Ironwood received an $85 million milestone payment from Forest for FDA approval of LINZESS.
  • Including the $85 million milestone payment, Ironwood ended the third quarter of 2012 with approximately $193 million of cash, cash equivalents, and available-for-sale securities and used approximately $47 million of net cash for operations during the nine months ended September 30, 2012.


Market Data powered by QuoteMedia. Terms of Use